Drug-drug interaction with two different route of administration [Design Issues]

posted by dshah  – India, 2022-07-20 12:27 (907 d 17:19 ago) – Posting: # 23151
Views: 3,054

hello Mr. Rao!
I think the information provided is too little. There are guidelines available for DDI in both FDA and EMA.
Regards,
Divyen Shah

Complete thread:

UA Flag
Activity
 Admin contact
23,359 posts in 4,905 threads, 1,672 registered users;
40 visitors (0 registered, 40 guests [including 12 identified bots]).
Forum time: 04:46 CET (Europe/Vienna)

You are rewarding a teacher poorly
if you remain always a pupil.    Friedrich Nietzsche

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5